Jan Hoflack

Jan Hoflack has an extensive work experience in the pharmaceutical and biotech industries. Jan currently holds the position of Chief Scientific Officer at Oncodesign Precision Medicine - OPM since 2022. Prior to this, they worked at Oncodesign as CSO and VP Discovery, leading new business units for integrated discovery programs as a service to partners. Jan also had leadership roles at Johnson & Johnson, AstraZeneca, and Novartis, where they were responsible for medicinal chemistry, enabling sciences and technologies, and structural biology and molecular modelling. Jan started their career as a Research Scientist at Marion Merrell Dow, where they worked on a CNS project and led a team of researchers.

Jan Hoflack completed their high school education from Sint-Lodewijkscollege Bruges between 1972 and 1978, majoring in Latin-Mathematics. Jan then pursued a PhD in Chemistry, specializing in Organic Synthesis, from State University Ghent, which they completed between 1980 and 1987.